Meeting News

VERSIFY substudy demonstrates benefits of IV Entyvio

August 2, 2019
SAN DIEGO — Patients with Crohn’s disease treated with IV Entyvio demonstrated considerable improvements in quality of life and work…
Meeting News

Stopping 5-ASA safe upon anti-TNF induction for Crohn’s disease

August 1, 2019
SAN DIEGO — Discontinuing 5-aminosalicylate therapy after starting anti-TNF therapy did not heighten the risk for adverse clinical events among…
Meeting News

Telephone straight-to-test strategy improves early diagnosis of IBD

July 16, 2019
SAN DIEGO — The telephone straight-to-test approach shortened the length of time from primary care referral to diagnosis of inflammatory bowel…
Meeting News

IgG, IgA levels help differentiate between UC, Crohn’s disease

July 12, 2019
SAN DIEGO — Levels of the anti-malondialdehyde-acetaldehyde adduct antibodies immunoglobulin G and immunoglobulin A act as serological…
Meeting News

Serum-based biomarker test yields positive diagnostic accuracy for Crohn’s disease

July 10, 2019
SAN DIEGO — The Mucosal Healing Index, a serum-based biomarker assay, demonstrated efficacy in identifying mucosal inflammation and similar…
Meeting News

Gut microbiota changes bile acid composition, affects phenotypic features of IBD

July 9, 2019
SAN DIEGO — Higher levels of bile acid-metabolizing microbiota correlated significantly with type and location of disease and mucosal…
Meeting News

Stelara demonstrates safety, efficacy in highly refractory Crohn’s disease

June 25, 2019
SAN DIEGO — Ustekinumab resulted in clinical remission of Crohn’s disease in more than half of patients in a large, highly refractory…
Meeting News

Low continuity of care in IBD worsens outcomes

June 17, 2019
SAN DIEGO — In patients with inflammatory bowel disease, continuity of care was found to be low and was associated with poorer outcomes…

Early initiation of Humira improves remission rates in Crohn’s disease

June 11, 2019
SAN DIEGO — Earlier introduction of adalimumab – within 2 years of diagnosis – substantially improves remission rates among…
Meeting News

Oral vancomycin induces, maintains remission of UC in patients with UC-PSC

May 30, 2019
SAN DIEGO — Oral vancomycin safely induced and maintained remission of ulcerative colitis among a subset of patients with ulcerative colitis…
Healio Jobs